GB2433032A — Syringe with dose adjustment means
Assigned to Owen Mumford Ltd · Expires 2007-06-13 · 19y expired
What this patent protects
A substance delivery device 1 for use with a container containing the substance, the device comprising: a body 2 arranged to house or hold the container 82; a plunger 40 which is movable with respect to at least a portion of the body 2, the plunger 40 being arranged to act upon t…
USPTO Abstract
A substance delivery device 1 for use with a container containing the substance, the device comprising: a body 2 arranged to house or hold the container 82; a plunger 40 which is movable with respect to at least a portion of the body 2, the plunger 40 being arranged to act upon the container 82 so as to move the container with respect to said portion of the body 2; wherein the plunger 40 is also arranged to expel at least a portion of the substance from the container 82; and wherein the device comprises means 44 for adjusting the amount of substance to be expelled from the container 82. The device may also comprise means 70 for priming the container 82.
Drugs covered by this patent
- naloxone-hydrochloride (Naloxone Hydrochloride) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.